Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Linde
LIN
|
+$764M |
| 2 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$574M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$418M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$344M |
| 5 |
UnitedHealth
UNH
|
+$284M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.28B |
| 2 |
Shopify
SHOP
|
+$370M |
| 3 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$351M |
| 4 |
Microsoft
MSFT
|
+$326M |
| 5 |
RP
RealPage, Inc.
RP
|
+$316M |
Sector Composition
| 1 | Technology | 16.42% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 12.02% |
| 4 | Consumer Discretionary | 11.76% |
| 5 | Industrials | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4001
Pennant Group
PNTG
$884M
| $618K | ﹤0.01% |
15,105
-16,624
| -52% | -$680K |
|
|
NEWR
4002
DELISTED
New Relic, Inc.
NEWR
| $618K | ﹤0.01% |
+9,227
| New | +$618K |
|
|
ALTA
4003
DELISTED
Altabancorp Common Stock
ALTA
| $616K | ﹤0.01% |
+14,234
| New | +$616K |
|
4004
Lumentum
LITE
$11.4B
| $614K | ﹤0.01% |
7,480
-222,074
| -97% | -$18.2M |
|
4005
Ryerson Holding
RYI
$723M
| $614K | ﹤0.01% |
+42,030
| New | +$614K |
|
4006
AvePoint
AVPT
$3.31B
| $613K | ﹤0.01% |
50,055
+35,987
| +256% | +$441K |
|
4007
Simmons First National
SFNC
$2.96B
| $613K | ﹤0.01% |
20,895
-234,351
| -92% | -$6.88M |
|
4008
Shenandoah Telecom
SHEN
$744M
| $613K | ﹤0.01% |
12,640
+4,800
| +61% | +$233K |
|
4009
Ribbon Communications
RBBN
$676M
| $612K | ﹤0.01% |
80,439
-64,573
| -45% | -$491K |
|
|
SIOX
4010
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $611K | ﹤0.01% |
223,677
-139,300
| -38% | -$381K |
|
|
OYST
4011
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $611K | ﹤0.01% |
35,559
-23,129
| -39% | -$397K |
|
|
TPGY
4012
DELISTED
TPG Pace Beneficial Finance Corp.
TPGY
| $611K | ﹤0.01% |
+47,442
| New | +$611K |
|
4013
Atmos Energy
ATO
$26.7B
| $609K | ﹤0.01% |
6,336
-222,406
| -97% | -$21.4M |
|
4014
AC Immune
ACIU
$244M
| $607K | ﹤0.01% |
76,569
-175,457
| -70% | -$1.39M |
|
4015
Vanguard Small-Cap Value ETF
VBR
$31.6B
| $607K | ﹤0.01% |
3,497
-6,500
| -65% | -$1.13M |
|
|
PRSU
4016
Pursuit Attractions and Hospitality, Inc.
PRSU
$1.04B
| $607K | ﹤0.01% |
12,182
-9,730
| -44% | -$485K |
|
4017
iShares MSCI Pacific ex Japan ETF
EPP
$1.85B
| $606K | ﹤0.01% |
+11,725
| New | +$606K |
|
4018
SPDR S&P Pharmaceuticals ETF
XPH
$184M
| $606K | ﹤0.01% |
+11,712
| New | +$606K |
|
4019
nLIGHT
LASR
$1.43B
| $605K | ﹤0.01% |
16,670
-97,856
| -85% | -$3.55M |
|
|
PTK
4020
DELISTED
PTK Acquisition Corp.
PTK
| $604K | ﹤0.01% |
+60,998
| New | +$604K |
|
|
DBTX
4021
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $601K | ﹤0.01% |
69,917
-73,553
| -51% | -$632K |
|
4022
Invesco KBW Bank ETF
KBWB
$4.98B
| $600K | ﹤0.01% |
+9,319
| New | +$600K |
|
4023
Prelude Therapeutics
PRLD
$64M
| $600K | ﹤0.01% |
20,958
+7,455
| +55% | +$213K |
|
4024
Union Bankshares
UNB
$118M
| $600K | ﹤0.01% |
16,563
-757
| -4% | -$27.4K |
|
4025
Vasta Platform
VSTA
$364M
| $596K | ﹤0.01% |
73,387
-76,444
| -51% | -$621K |
|